Patents by Inventor Ian Hampson
Ian Hampson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12083120Abstract: The present invention concerns pharmaceutical compositions formulated for dermal application comprising a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically acceptable vehicle and wherein the weight ratio (w/w) of lopinavir:ritonavir is between 9:1 and 18:1. Such compositions are useful for treating, or preventing, skin cancers and premalignant dermal conditions.Type: GrantFiled: May 23, 2019Date of Patent: September 10, 2024Assignee: Douglas Pharmaceuticals LTD.Inventors: Ian Hampson, Lynne Hampson
-
Publication number: 20240148729Abstract: The present invention concerns pharmaceutical compositions formulated for topical application that are useful in the treatment of HPV-related pathologies and in particular the treatment of premalignant and malignant conditions of the cervix. The compositions comprise a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically acceptable vehicle and wherein the weight ratio (w/w) of lopinavir:ritonavir is between 9:1 and 18:1.Type: ApplicationFiled: June 30, 2023Publication date: May 9, 2024Applicant: DOUGLAS PHARMACEUTICALS LIMITEDInventors: Ian Hampson, Lynne Hampson
-
Patent number: 11738024Abstract: The present invention concerns pharmaceutical compositions formulated for topical application that are useful in the treatment of HPV-related pathologies and in particular the treatment of premalignant and malignant conditions of the cervix. The com-positions comprise a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically acceptable vehicle and wherein the weight ratio (w/w) of lopinavir: ritonavir is between 9:1 and 18:1.Type: GrantFiled: May 23, 2019Date of Patent: August 29, 2023Assignee: Douglas Pharmaceuticals LimitedInventors: Ian Hampson, Lynne Hampson
-
Publication number: 20220257771Abstract: Provided herein are methods and compositions for treating and/or inhibiting the development or progression of conditions caused by, or associated with, Herpes Simplex Virus (HSV)infection. In particular, provided are compositions comprising lopinavir alone, or lopinavir and ritonavir, methods for their manufacture; and the use of said pharmaceutical compositions as a medicament. In particular, pharmaceutical compositions are provided for use in treating and/or inhibiting the progression of HSV related conditions.Type: ApplicationFiled: May 20, 2020Publication date: August 18, 2022Applicant: DOUGLAS PHARMACEUTICALS LIMITEDInventors: Ian Hampson, Lynne Hampson, Fergus Cameron Binnie, Peter Surman
-
Publication number: 20210213015Abstract: The present invention concerns pharmaceutical compositions formulated for topical application that are useful in the treatment of HPV-related pathologies and in particular the treatment of premalignant and malignant conditions of the cervix. The compositions comprise a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically acceptable vehicle and wherein the weight ratio (w/w) of lopinavir: ritonavir is between 9:1 and 18:1.Type: ApplicationFiled: May 23, 2019Publication date: July 15, 2021Applicant: DOUGLAS PHARMACEUTICALS LIMITEDInventors: Ian Hampson, Lynne Hampson
-
Publication number: 20210213016Abstract: The present invention concerns pharmaceutical compositions formulated for dermal application comprising a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically acceptable vehicle and wherein the weight ratio (w/w) of lopinavir: ritonavir is between 9:1 and 18:1. Such compositions are useful for treating, or preventing, skin cancers and premalignant dermal conditions.Type: ApplicationFiled: May 23, 2019Publication date: July 15, 2021Applicant: DOUGLAS PHARMACEUTICALS LTDInventors: Ian Hampson, Lynne Hampson
-
Patent number: 10251884Abstract: Disclosed herein are compositions comprising lopinavir alone or in combination with ritonavir for use as a medicament in the treatment of cancer or benign proliferative disorders (warts) or in the prevention of the development of cancer. Pharmaceutical compositions formulated for topical application comprising a therapeutically effective amount of lopinavir or a therapeutically effective amount lopinavir and ritonavir in a pharmaceutically acceptable vehicle are also provided. Also disclosed are methods of treating a patient having an HPV related dysplasia of the cervix comprising administering to said patient a therapeutically effective dose of the disclosed pharmaceutical compositions.Type: GrantFiled: September 5, 2017Date of Patent: April 9, 2019Assignee: The University of ManchesterInventors: Ian Hampson, Lynne Hampson
-
Publication number: 20180161328Abstract: Disclosed herein are compositions comprising lopinavir alone or in combination with ritonavir for use as a medicament in the treatment of cancer or benign proliferative disorders (warts) or in the prevention of the development of cancer. Pharmaceutical compositions formulated for topical application comprising a therapeutically effective amount of lopinavir or a therapeutically effective amount lopinavir and ritonavir in a pharmaceutically acceptable vehicle are also provided. Also disclosed are methods of treating a patient having an HPV related dysplasia of the cervix comprising administering to said patient a therapeutically effective dose of the disclosed pharmaceutical compositions.Type: ApplicationFiled: September 5, 2017Publication date: June 14, 2018Applicant: The University of ManchesterInventors: Ian Hampson, Lynne Hampson
-
Patent number: 9782409Abstract: Disclosed herein are compositions comprising lopinavir alone or in combination with ritonavir for use as a medicament in the treatment of cancer or benign proliferative disorders (warts) or in the prevention of the development of cancer. Pharmaceutical compositions formulated for topical application comprising a therapeutically effective amount of lopinavir or a therapeutically effective amount lopinavir and ritonavir in a pharmaceutically acceptable vehicle are also provided. Also disclosed are methods of treating a patient having an HPV related dysplasia of the cervix comprising administering to said patient a therapeutically effective dose of the disclosed pharmaceutical compositions.Type: GrantFiled: October 23, 2014Date of Patent: October 10, 2017Assignee: The University of ManchesterInventors: Ian Hampson, Lynne Hampson
-
Publication number: 20160271132Abstract: Disclosed herein are compositions comprising lopinavir alone or in combination with ritonavir for use as a medicament in the treatment of cancer or benign proliferative disorders (warts) or in the prevention of the development of cancer. Pharmaceutical compositions formulated for topical application comprising a therapeutically effective amount of lopinavir or a therapeutically effective amount lopinavir and ritonavir in a pharmaceutically acceptable vehicle are also provided. Also disclosed are methods of treating a patient having an HPV related dysplasia of the cervix comprising administering to said patient a therapeutically effective dose of the disclosed pharmaceutical compositions.Type: ApplicationFiled: October 23, 2014Publication date: September 22, 2016Applicant: The University of ManchesterInventors: Ian HAMPSON, Lynne HAMPSON
-
Publication number: 20130046098Abstract: The present invention relates to compounds of formula (I): wherein A=formula: (a) or formula: (b); X is oxygen or methylene; Y is C3-6 alkyl or aryl; Z is oxygen or C1-3 alkyl; R1 is hydrogen or C1-3 alkyl; R2 is hydrogen or C1-3 alkyl; the or each R3 is separately C1-3 alkyl or halo; the or each R4 is separately C1-3 alkyl or halo; p is 0 to 4; q is 0 to 4; m is 0 or 1; and n is 1 to 3. These compounds are useful as kinase inhibitors for the treatment of cancer and other diseases.Type: ApplicationFiled: August 20, 2010Publication date: February 21, 2013Applicant: THE UNIVERSITY OF MANCHESTERInventors: Lynne Hampson, Ian Hampson, John Anthony Hadfield, Timothy Patrick Kemp, Alan Thomson McGowan
-
Publication number: 20050233310Abstract: The present invention relates to a method of screening a protein for involvement in cancer. The method involves the steps of: exposing the protein to a first viral oncoprotein; assaying for interaction of the protein and the first viral oncoprotein; exposing the protein to a second viral oncoprotein; and assaying for interaction of the protein and the second viral oncoprotein. Interaction of the protein with the viral oncoproteins indicates that the protein is involved in cancer.Type: ApplicationFiled: March 11, 2003Publication date: October 20, 2005Inventors: Ian Hampson, Lynne Hampson